Skip to main content
Premium Trial:

Request an Annual Quote

Not Yet a Need

An international group of experts says most people do not yet need a SARS-CoV-2 vaccine booster, the New York Times reports.

In a commentary appearing in the Lancet, the team — which includes World Health Organization officials, two outgoing US Food and Drug Administration officials, and others — says currently available evidence does not support the need for vaccine boosters for most people who are not immunocompromised. The authors write that, to date, studies have not shown a decline in the protection vaccines provide against severe COVID-19, though a decrease in protection against symptomatic disease has occurred.

As the Associated Press notes, the commentary authors include Phil Krause and Marion Gruber, two FDA officials who recently announced they would be leaving their positions. Endpoints News reported last week that the pair was bothered by "the White House getting ahead of FDA on booster shots." The Biden Administration announced in August that US adults would be eligible for a booster eight months after receiving their second Pfizer or Moderna vaccine doses.

"It's always a fundamental error of process to make a scientific announcement before the public health agencies have acted and that's exactly what happened here," Georgetown University's Larry Gostin tells the AP.

Additionally, the WHO has called for a moratorium on vaccine boosters until more of the world has received their initial inoculations.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.